“Shonan Health Innovation Park (hereinafter Shonan iPark)” is a science park established by Takeda Pharmaceutical Company Limited, a globally operating pharma company. Research space offered by the park is taken up by companies and organizations of a broad array of business lines and sizes from industry, academia and government, including pharma makers, firms related to next-generation medical treatment, artificial intelligence, medical equipment, venture capital companies, and administrative bodies. The park thus functions as a domestic base for promoting open innovation concerning healthcare.
This time around, Industrial & Infrastructure Fund Investment Corporation, the only REIT for industrial real estate in Japan, used a real estate bridge scheme proposed by our Group company in acquiring an equity stake in Shonan iPark. The Group favored the idea that the REIT & Shonan iPark sought to “Build a Life-science Ecosystem that is open to the world” by improving the value of park facilities through the equity acquisition, and thereby offered the bridge scheme through our Group company.
